Contact this trialFirst, we need to learn more about you.
NK Cell Therapy
Memory-like NK Cell Therapy + BHV-1100 for Multiple Myeloma
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing a new treatment for multiple myeloma that involves infusing patients with a combination of cytokine-induced memory-like natural killer cells and KP1237, with low-dose IL-2. The primary objective is to establish the safety of this treatment, and to explore its efficacy in patients who have minimal residual disease in first remission prior to autologous stem cell transplant.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service